On-Demand Webinar: Modelling Neurodegenerative Disorders in 3D Models
Overview
Join us to explore the revolutionary advancements in brain research made possible by induced pluripotent stem cells (iPSCs) and 3D brain organoids. These cutting-edge technologies allow researchers to work with and visualize living human neuronal tissue, closely mimicking distinct regions of the human brain.
An "Automated 3D brain organoid imaging platform" equipped with liquid handling, live cell capabilities, and high-end confocal optics is essential for deep phenotyping brain organoids when generated in large batches of hundreds, or for profiling other 3D neuronal models from our ever-growing cohort of patient-derived iPSCs.
By integrating these advanced technologies, we aim to enhance our understanding of neuronal network development, the mechanisms of neuron death, and the underlying causes of brain disorders. Don't miss this opportunity to gain valuable insights into the future of brain research.
Complete the Form to Access the Webinar
In This Webinar We Will:
- Demonstrate how we combine brain organoids with automated high-content imaging to observe brain development in real-time and test new technologies.
- Learn about the growth process of brain organoids and how single-cell phenotyping can unravel the complexities and cell compositions within these tissues.
- Explore the use of spheroid models in conjunction with microfluidics to model neuromuscular junctions, particularly for ALS studies.
Webinar Speaker
Thomas M Durcan, Ph.D
Director, The Neuro's Early Drug Discovery Unit (EDDU),
Killam Research Scholar,
Associate Professor, The Neuro, McGill University
Dr. Thomas M. Durcan is an Associate Professor within the Montreal Neurological Institute (The Neuro) and McGill University and Director of the Neuro’s Early Drug Discovery Unit (EDDU), focused on the use of human induced pluripotent stem cells (iPSCs) for fundamental and translational discovery project through partnerships with academia and industry.
